The YAP/TEAD Axis as a New Therapeutic Target in Osteosarcoma: Effect of Verteporfin and CA3 on…
Although some studies suggested that disruption of the Hippo signaling pathway is associated with osteosarcoma progression, the molecular mechanisms by which YAP regulates primary tumor growth is not fully clarified.
- Ref: Cancers (Basel). 2020 Dec 20;12(12):3847.
- Année de publication : 2020
- Auteurs : Morice S, Mullard M, Brion R, Dupuy M, Renault S, Tesfaye R, Brounais-Le Royer B, Ory B, Redini F, Verrecchia F.
- Réseaux : Réseaux: « Niches et Epigénétique des Tumeurs » & « Vectorisation, Imagerie, Radiothérapies »